Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Bethesda, MD

105 studies for Prostate Cancer are recruiting at 173 sites within 50 miles of Bethesda, Maryland, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Bethesda.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Bethesda

Showing the 50 nearest of 105 studies.
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Walter Reed National Military Medical Center (Bethesda, MD); MedStar Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  2. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Bethesda, MD); Massive Bio SYNERGY-AI site (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  3. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    NCT03866382

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: National Institutes of Health Clinical Center (Bethesda, MD); MedStar Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Suburban Hospital (Bethesda, MD); Sibley Memorial Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Walter Reed National Military Medical Center (Bethesda, MD); Inova Fair Oaks Hospital (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  6. Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

    NCT06257693

    • Phase 1
    • Ages 21 years and older
    • Sex: Male

    Nearest sites: National Institutes of Health Clinical Center (Bethesda, MD); Johns Hopkins University School of Medicine (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. Collection of Blood From Patients With Cancer

    NCT00034216

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

    NCT00451022

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Collection of Blood From Patients With Prostate Cancer

    NCT00923221

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

    NCT01441089

    • Observational
    • Ages 3 years and older
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy

    NCT01834001

    • Observational
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue

    NCT02594202

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

    NCT03354416

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Men at High Genetic Risk for Prostate Cancer

    NCT03805919

    • Observational
    • Ages 30 to 75 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

    NCT04633252

    • Phase 1/2
    • Ages 18 to 110 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

    NCT04692675

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Precision-Based Genomics in Prostate Cancer

    NCT04706663

    • Observational
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

    NCT05155046

    • Phase 2
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

    NCT05361798

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

    NCT05588128

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

    NCT05616650

    • Phase 2
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

    NCT06096870

    • Phase 2
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

    NCT06161506

    • Phase 2
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

    NCT07667400

    • Phase 1/2
    • Ages 18 to 120 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

    NCT07686380

    • Phase 2
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Study of ORIC-944 in Patients With Metastatic Prostate Cancer

    NCT05413421

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Maryland Oncology Hematology (Silver Spring, MD); Virginia Oncology Associates (Fairfax, VA)

    Distance to nearest recruiting site
    ~4 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  27. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: George Washington University Medical Center (Washington D.C., DC); UM Capital Region Medical Center (Largo, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  28. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MedStar Washington Hospital Center ( Site 0103) (Washington D.C., DC); Inova Schar Cancer Institute ( Site 0017) (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  29. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: George Washington University Medical Center (Washington D.C., DC); Sibley Memorial Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  30. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital (Washington D.C., DC); Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  31. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    NCT04787744

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Washington DC VA Medical Center, Washington, DC (Washington D.C., DC); Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  32. Clinical Trial of Approaches to Prostate Cancer Surgery

    NCT05155501

    • Interventional
    • Ages 40 to 80 years
    • Sex: Male

    Nearest sites: Georgetown University (Washington D.C., DC); Johns Hopkins University (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  33. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University, Sibley Memorial Hospital (Washington D.C., DC); Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  34. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Georgetown University Medical Center (Washington D.C., DC); Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  35. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Washington DC Veterans Affairs Medical Center ( Site 0056) (Washington D.C., DC); Greenebaum Comprehensive Cancer Center ( Site 0021) (Baltimore, MD)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  36. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    NCT06931340

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: MedStar Georgetown University Hospital (Washington D.C., DC); MedStar Washington Hospital Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  37. Cancer Experience Registry (CER) for Cancer Patients and Caregivers

    NCT02333604

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Cancer Support Community Research & Training Institute (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: George Washington University Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    NCT04038502

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Washington DC VA Medical Center, Washington, DC (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    NCT05803941

    • Phase 4
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: VA Medical Center (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Castrate Resistant Prostate Cancer Enhertu Therapy

    NCT06610825

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Washington DC VAMC (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

    NCT06863272

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

    NCT07644598

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Lombardi Comprehensive Cancer Center, Georgetown University (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

    NCT07365995

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Maryland Oncology Hematology (Rockville, MD); Virginia Cancer Specialists PC (Fairfax, VA)

    Distance to nearest recruiting site
    ~8 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  45. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Virginia Cancer Specialists (Fairfax, VA); Johns Hopkins Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  46. ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

    NCT04986423

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Virginia Cancer Specialists (Fairfax, VA); Maryland Oncology Hematology, P.A. (Columbia, MD)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  47. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Virginia (Fairfax, VA); Sidney Kimmel Comprehensive Cancer Center at John Hopkins (Baltimore, MD)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  48. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site 102 (Fairfax, VA); Research Site 112 (Fairfax, VA)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  49. A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

    NCT06785636

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: NEXT Oncology - Virginia (Fairfax, VA); Johns Hopkins Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  50. Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

    NCT00969111

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Inova Schar Cancer Institute (Fairfax, VA)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.